Valuation: Biogen Inc.

Market Cap 29.85B 26.22B 24.38B 22.37B 42.04B 2,875B 42.69B 290B 113B 1,413B 112B 110B 4,886B P/E 2026 *
25.1x
P/E 2027 * 16x
Enterprise Value 35.17B 30.89B 28.72B 26.36B 49.52B 3,387B 50.29B 341B 133B 1,665B 132B 129B 5,757B EV / Sales 2026 *
3.49x
EV / Sales 2027 * 3.21x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.78%
1 week-1.84%
Current month-6.42%
1 month+1.30%
3 months+9.66%
6 months+17.83%
Current year+14.89%
1 week 196.92
Extreme 196.915
205.65
1 month 186.02
Extreme 186.025
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 124.56
Extreme 124.5561
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
9/6/26 Free

Director

1,505 0.0010%
9/6/26 Free

Chairman

2,005 0.0014%
9/6/26 Fiscal year

Director

6,245 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%-1.84%+52.49%-27.01% 29.85B
+0.63%-3.06%+16.18%-9.78% 66.74B
+1.23%+2.80%+37.51%+202.14% 53.32B
+10.08%+51.80%+51.80%+51.80% 48.12B
-1.32%-7.38%-57.63%-57.10% 38.25B
+0.84%+0.36%+66.93%+85.42% 23.51B
-5.17%-12.54%+58.98%-56.04% 21.45B
-1.21%+1.12%+1.98%+170.93% 19.97B
-0.22%-0.95%+61.97%+123.78% 16.38B
+1.31%+3.24%+84.01%+152.77% 16.47B
Average +1.29%-0.57%+37.42%+63.69% 33.41B
Weighted average by Cap. +1.78%+0.06%+30.57%+55.05%

Financials

2026 *2027 *
Net sales 10.06B 8.84B 8.22B 7.54B 14.17B 969B 14.39B 97.61B 38.14B 476B 37.78B 36.97B 1,647B 10.32B 9.06B 8.43B 7.73B 14.53B 994B 14.75B 100B 39.1B 489B 38.73B 37.9B 1,689B
Net income 1.29B 1.13B 1.05B 966M 1.82B 124B 1.84B 12.5B 4.88B 61.03B 4.84B 4.74B 211B 1.99B 1.74B 1.62B 1.49B 2.8B 191B 2.84B 19.27B 7.53B 94.05B 7.46B 7.3B 325B
Net Debt 5.32B 4.67B 4.34B 3.98B 7.49B 512B 7.6B 51.56B 20.14B 252B 19.95B 19.52B 870B 3.23B 2.83B 2.64B 2.42B 4.54B 311B 4.61B 31.3B 12.23B 153B 12.12B 11.85B 528B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
24/07/26 US$202.19 +0.78% 596,372
23/07/26 US$200.62 +1.46% 1,032,070
22/07/26 US$197.74 -2.67% 841,350
21/07/26 US$203.16 +1.61% 652,841
20/07/26 US$199.95 -2.93% 963,088
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
202.19USD
Average target price
227.59USD
Spread / Average Target
+12.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock